Latest News

Private Equity Perspective on Life Settlements at the Fasano Longevity Conference

Cornell Capital is an innovative private equity firm with a strong position in the financial services and insurance industries. They recently purchased Longevity Holdings, the parent company of Fasano Associates, Maple Life Financial, PBI Research Services and Life Insurance Trust Company, among others.

Said Mike Fasano: “Cornell Capital will be leveraging its formidable skill set across longevity and life settlement markets. Emily Pollack is one of their key players and has proven herself to be an astute deal maker. I’m very much looking forward to hearing her insights.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. The $595 registration fee includes cocktails and dinner immediately following the Conference.

Fasano Conference to Highlight Machine Learning Applications for Life Expectancy Underwriting

The structured settlement demographic is very different than the life insurance/settlements population. As a consequence, the underwriting approach as well as the underlying data differ substantially. While ample medical information from physician and hospital reports typically is available for life settlement underwriting, clinical documentation for the structured settlement population is less consistent; and while medical information explains much of the mortality expectations for life insurance and life settlements, behavioral factors are more relevant for mortality in the structured settlement population.

To analyze the factors explaining and driving mortality in the structured settlement population, Dr. Bauer and his colleagues at the University of Wisconsin have taken underwriting reports from surveys, interviews, and criminal/drug history reports, and applied semi-supervised machine learning approaches to automatically discover meaningful features from the unstructured text data.

Said Mike Fasano: “This promises to be an extremely interesting presentation. Dani’s research is state-of-the-art, and we are hoping that it will shed light on statistically meaningfully features driving mortality in the structured settlement population.

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets it has been favored by the investment and financial community. Cocktails and dinner immediately follow the Conference. Register Now!

Jay Jackson’s Vision for Life Settlement Industry Growth at the Fasano Longevity Conference

Jackson will discuss technological and capital structure changes that he believes are needed to put the life settlement industry on an exponential growth path. Said Mike Fasano, “Jay is very much a forward thinker and has put together some really innovative programs at Abacus. I am very much looking forward to his presentation.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. The $595 registration fee includes cocktails and dinner immediately following the Conference.

New Drug to Reduce Aging at Fasano Longevity Conference

Dr. Vaughan is Director of the Potocsnak Longevity Institute at Northwestern University. He and his colleagues have developed a drug to reduce PAI-1 levels, a protein associated with blood clotting that causes a number of aging related disorders, as well as more severe COVID outcomes.

Said Fasano Associates’ Mike Fasano, “Doug’s research offers the prospect of reduced morbidity and mortality in the senior population, and also offers a promising therapy to deal with the effects of long COVID. His will be a fascinating presentation.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. Register now and save over 15% off the regular $595 registration fee.

Jason Sutherland to Cover Structured Settlement Market at Fasano Longevity Conference

Said Mike Fasano, “Jason brings over 23 years of experience in specialty finance markets with him. He combines both detailed deal making talent with a policy level perspective and understands the structured settlement market as well as anyone. I am very much looking forward to his presentation.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. Register now and save over 15% off the regular $595 registration fee.

Groundbreaking Spinal Cord Research at Fasano Longevity Conference

Dr. Stupp is founding director of the Simpson Querrey Institute for BioNanotechnology and the Center for Regenerative Nanomedicine. His research team has developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal cord injuries.

Said Fasano Associates’ Mike Fasano, “Sam’s research will be game changing. His therapy offers the chance to finally improve quality of life and life expectancy for spinal cord injury victims. His presentation will be particularly interesting to anyone with an interest in structured settlements or impaired life cases.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. Register now and save over 15% off the regular $595 registration fee.

200 Attend Fasano Longevity Conference Focused on Investments, Mortality Research, and Life Settlements

Fasano Longevity Conference to Cover Investments, Mortality Research and Life Settlements

WASHINGTON, D.C.-(BUSINESS WIRE)-October 19, 2021: The Fasano Longevity Conference, which will be held on November 1st, will include a wide range of topics bearing on longevity markets, mortality and the economy.

The Conference will start this year with an analysis of the Post-Covid Investment Outlook by keynote speaker, Tony Roth – Chief Investment Officer of Wilmington Trust.  Tony will be followed by two research presentations: The Risks and Benefits of Marijuana versus Opioids in Pain Relief by Dr. Steven Rigatti and The Impact of Sex on Gene Expression, Disease and Mortality by Dr. Barbara Stranger of Northwestern University.

The morning sessions will end with a “State of the Life Settlement Market” presentation by LISA Executive Director, Bryan Nicholson, while the afternoon sessions will begin with a legal analysis of current STOLI litigation affecting the life settlement industry by James Westerlind of Arent Fox and Kenneth Brown of Williams & Connolly.

The final three sessions will cover different aspects of mortality: Matt Morton, Chief Actuary of LTCG, will draw on an extensive database of long-term care patients and share his insight on the changes in mortality that occur as functional status declines, while PBI CEO, John Bikus, will detail how artificial intelligence and obituary research has filled the death identification gap created by regulatory changes limiting the efficacy of the Master Death File.

The Conference will close with an analysis by Dan Zollars of Maple Life Analytics of Mortality Differences in Secondary versus Tertiary Life Settlement Markets.

Said Michael Fasano, President of Fasano Associates, “This year’s Conference covers a very interesting mix of investment, life settlement industry and research issues.” Fasano described his Conference as “Investor Focused.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets and has been favored by the investment and financial community. This year’s Conference will be live in Washington, DC, although a virtual option will be offered to those not yet ready to travel: https://fasanoassociates.com/annual-conference-2021/

Discounts from the $495 Conference fee will be available to LISA, ELSA, ILMA and BVZL trade association members.

About Fasano Associates:

Fasano Associates is a leading underwriting consulting firm serving the life, health, annuity and life settlement industries.

Contact Information:

Mike Fasano
mfasano@fasanoassociates.com
www.fasanoassociates.com
202-457-8188

Tony Roth, Chief Investment Officer of Wilmington Trust, to Keynote Fasano Longevity Conference

Tony has been Chief Investment Officer for Wilmington Trust Investment Advisors, the investment advisory arm of M&T Bank Corporation, since 2014.  Before that, he served as CIO of Acquitaine Management.

Said Mike Fasano, President, Fasano Associates, “There is a tremendous amount of uncertainty as to the ultimate impact of the Covid crisis on life settlement, fixed income and other institutional caliber investments. Tony Roth is a creative thinker whose insights on the post-Covid investment outlook will make for a great start to our Conference.”

The Fasano Conference will be live this year in Washington, DC, but will offer a virtual option for those who would prefer not to travel.  The Conference fee has been locked in at the special, Early Bird rate of only $495. Trade association members (LISA, ELSA, ILMA & BVZL) are eligible for courtesy discounts from the $495 Conference fee.

The Changing Landscape of Death Audit at Fasano Longevity Conference

Said Mike Fasano, President of Fasano Associates: “The 2011 restrictions on SSA Death Master File (DMF) reporting turned the life settlement industry upside down and made Actual to Expected accuracy analysis for life expectancy underwriters much more difficult.  Thanks to the efforts of PBI and similar death research organizations, we now have new sources of information and better death reporting than before the DMF changes.  John’s presentation will shed light on the ever-changing death audit process.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets and has been favored by the investment and financial community. The $595 registration fee includes cocktails and dinner immediately following the Conference.

LISA Executive Director to Address the Fasano Longevity Conference

Bryan will discuss the past, present and future of the life settlement market. Said Mike Fasano, President of Fasano Associates, “Our industry has gone through challenging times over the last two years – both due to Covid and from emerging legal and regulatory challenges that have impacted the life settlement industry. Bryan has been the right person to help steer the industry through these challenges.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets and has been favored by the investment and financial community. The early bird registration fee of $495 is still available, until September 24^th.

EARLY BIRD RATE WILL EXPIRE SEPTEMBER 24TH!

Register NOW and take advantage of the “EARLY BIRD RATE” of only $495!

A $100 SAVINGS OFF THE REGULAR CONFERENCE RATE!

THE EARLY BIRD RATE WILL EXPIRE SEPTEMBER 24^TH!

Here’s What You Get:

• Time efficient, one-day Conference in EASY to ACCESS, Washington DC

• Substance packed agenda, including 8 Presentations with topics impacting all aspects of the Longevity Markets

• All followed by the Best Networking Venue with Cocktails and Dinner

• Register now! And take advantage of the Early Bird Rate BEFORE IT EXPIRES!

For complete conference details, click on the links below or call us at 202-457-8188

Pot versus Opioids: Pros & Cons at Fasano Longevity Conference

Dr. Rigatti is Founder of Rigatti Risk Analytics and former Chief Medical Director of Mass Mutual.  His presentation will look at the mortality and morbidity associated with marijuana versus opioid use and compare their efficacy in treating pain and for other medical purposes.

Said Mike Fasano, President of Fasano Associates, “We have seen the adverse effect of opioid abuse in our underwriting business, and many have advocated marijuana as a safer alternative.  However, it has been hard to separate out the socioeconomic variables that correlate with adverse outcomes for both marijuana and opioid users.  Dr. Rigatti’s research will help to get us on the right path to rational analysis of the pros and cons of both marijuana and opioid use.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets it has been favored by the investment and financial community. The $495 early bird registration fee (good until September 24^th) includes cocktails and dinner immediately following the Conference.

Genetics of Sex Differences to be Covered at Fasano Longevity Conference

Dr. Stranger is an Associate Professor in the Center for Genetic Medicine at Northwestern University, and is an expert in the genetics of sex differences in human complex traits and disease. Her presentation will focus on how sex based genetic variation contributes to variation in human traits, disease risk and longevity.

Said Mike Fasano, President of Fasano Associates, “Dr. Stranger’s research is cutting edge and will give us greater insight into how human genetic variation impacts gene expression, and how these relationships can impact disease risk and ultimately life expectancy.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. The $495 early bird registration fee includes cocktails and dinner immediately following the Conference.

WASHINGTON, D.C.-(BUSINESS WIRE)-November 3, 2020: 240 longevity professionals attended the November 2nd Fasano Longevity Conference.  The Conference, which was in virtual format, focused on politics, Covid-19 and epigenetic research.

The Conference opened with a Perspective on the Life Settlement Industry presented by Kurt Bolin, Principal of Stone Point Capital, a large private equity firm.  Bolin was followed by Washington insider, Jack Kelly, who analyzed the impact of COVID-19 on this year’s controversial Presidential election, as well as the key counties that will give an early signal as to the likely outcome.

The keynote speaker was Dr. Steve Horvath, a pioneer in epigenetic research, who focused on the remarkable predictive power of epigenetics.

Fred Love, President of the National Association of Settlement Purchasers (NASP), gave his thoughts on some of the issues facing the Secondary Market for Structured Settlements.  He was followed by a trio of presentations on the topic of the day, COVID-19:

The Long-Term Mortality Impact of COVID-19 was analyzed by Dr. Andrew Cairns, Professor of Financial Mathematics at Heriot-Watt University in Edinburgh and Stuart McDonald, Head of Demographic Assumptions and Methodology at Lloyds Banking Group.

Two Northwestern University professors, Drs. Rick Zinbarg and Robin Nusslock, presented their original research on the Psychological Impact of COVID-19.

The Conference ended with an eye-opening presentation by economist, Eugene Steurele, who framed the economic impact of COVID-19 in a setting of uncontrolled deficit spending that has threatened the viability of both Medicare and Social Security.

Said Michael Fasano, President of Fasano Associates, “This year’s Conference laid out the multi-faceted impact of Covid-19 on our lives and the economy and also included original epigenetic research and a practical look at the life settlement and structured settlement markets.”  Fasano described his Conference as “Investor Focused”.  He added: “This year’s virtual format was certainly different and we all missed the face to face dynamic of a live conference, but the content was very strong and there was a good exchange of ideas between the speakers and the audience.”

DVDs of the Conference are available (mfasano@fasanoassociates.com) for $195. Next year’s Fasano Longevity Conference will be held on Monday, November 1st in Washington, DC.

About Fasano Associates:

Fasano Associates is a leading underwriting consulting firm serving the life, health, annuity and life settlement industries.

Contact Information:

Mike Fasano
mfasano@fasanoassociates.com
www.fasanoassociates.com
202-457-8188

WASHINGTON, D.C.-(BUSINESS WIRE)-October 20, 2020: The Fasano Longevity Conference, which will be held on November 2nd, will include a wide range of topics bearing on longevity markets, our health and the economy.

The Conference will start this year with a Private Equity Investor’s Perspective on the Life Settlement Industry by Kurt Bolin, Principal of Stone Point Capital.   Kurt will be followed by Washington insider, Jack Kelly, who will give us his insight and analysis on this year’s controversial Presidential election.

The keynote speaker is Dr. Steve Horvath, a pioneer in epigenetic research.  Steve will be presenting on Epigenetics and Biomarkers: A New Age in Longevity Modeling, and will focus on some of the newer longevity modeling approaches developed from his epigenetic research.

The National Association of Settlement Purchasers (NASP) will be represented again this year, with a presentation by NASP’s President, Fred Love, of his thoughts on the Secondary Market for Structured Settlements.  Mr. Love will be followed by a trio of presentations on the topic of the day, COVID-19:

Dr. Andrew Cairns, Professor of Financial Mathematics at Heriot-Watt University in Edinburgh, will give a modeling perspective to the Long-Term Mortality Impact of COVID-19, while Stuart McDonald, Head of Demographic Assumptions and Methodology at Lloyds Banking Group, will add an actuary’s views.

Andrew and Stuart will be followed by two Northwestern University professors, Drs. Rick Zinbarg and Robin Nusslock, who will present their extremely interesting, original research on the Psychological Impact of COVID-19.

The Conference ends with an eye-opening presentation by economist, Eugene Steurele, on the Implications of COVID-19 for the Economy and Government Policy.

Said Michael Fasano, President of Fasano Associates, “This year’s Conference lays out the multi-faceted impact of Covid-19 on our lives and the economy, and also includes original epigenetic research, and a practical look at the life settlement and structured settlement markets.”  Fasano described his Conference as “Investor Focused”.

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. This year the Conference will be delivered in virtual format, value priced at $195.

About Fasano Associates:

Fasano Associates is a leading underwriting consulting firm serving the life, health, annuity and life settlement industries.

Contact Information:

Mike Fasano
mfasano@fasanoassociates.com
www.fasanoassociates.com
202-457-8188

Noted Economist to Discuss Economic Impact of Covid-19 at Fasano Conference

Dr. Steuerle is a Fellow at the Urban Institute and Co-Chair of the Urban-Brookings Tax Policy Center. He has published widely on budget, finance and public policy issues and previously served as Deputy Assistant Secretary for Tax Policy at the U.S. Department of Treasury.

His talk at the Fasano Conference will cover the interrelated pressures of the Covid-19 pandemic & recession, unsustainable growth in debt, and the anticipated Social Security & Medicare collapse. These pressures will hurt young, working families, people of color, and will limit opportunity for all.

Said Mike Fasano, President of Fasano Associates: “Researchers have understandably focused on the medical impact of Covid-19; but the economic impact has and will be equally important to our society. Gene’s analysis is eye-opening, but it is important that we face the harsh economic reality that will affect us for years to come.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. This year the Conference will be delivered in virtual format, value priced at $195.

Long-Term Mortality Impact of COVID-19 at Fasano Longevity Conference

Dr. Cairns is Professor of Financial Mathematics at Heriot-Watt University in Edinburgh and is a Fellow of the Royal Society of Edinburgh, Scotland’s National Academy of Science and Letters. He recently co-authored a research paper on the Impact of Covid-19 on Future Higher-Age Mortality.

Stuart McDonald is Head of Demographic Assumptions and Methodology at Lloyds Banking Group.  He is a Fellow of the Institute of Actuaries and a chartered Enterprise Risk Actuary.  He has been active in following Covid-19 research and statistics.

Said Mike Fasano, President of Fasano Associates, “Andrew brings a modeling mindset to the question as to what the longer term mortality impact of Covid-19 will be, while Stuart adds an actuarial perspective.  Anyone investing in longevity related assets should want to hear what they have to say.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. This year the Conference will be delivered in virtual format, value priced at $195.

Groundbreaking Geneticist to Keynote Fasano Longevity Conference

Dr. Horvath, UCLA Professor in Human Genetics and Biostatistics, is the developer of the “Horvath” Epigenetic Clock, a biochemical test that determines the age of body tissues and organs.  His presentation will focus on some of the newer longevity modeling approaches developed from his epigenetic research.

Said Mike Fasano, President of Fasano Associates, “Steve is truly a pioneer in the field of epigenetic research.  Of all the research of the last decade to develop new tools to help measure aging and predict life expectancy, Steve’s work by far offers the most potential.  Anyone with an interest in longevity related investments will want to see his presentation.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. This year the Conference will be delivered in virtual format, value priced at $195.

THE 2020 FASANO
LONGEVITY CONFERENCE:

Private Equity Perspective on Life Settlements

Stone Point Capital LLC is a financial services-focused private equity firm based in Greenwich, CT. The firm has raised and managed eight private equity funds – the Trident Funds – with aggregate committed capital of $26 billion.  Stone Point targets investments in companies in the global financial services industry and related sectors.

Stone Point Capital has been focused on the life settlement industry for 20+ years.  Mike Fasano, President of Fasano Associates, said: “Private equity firms have a different perspective than hedge funds and other investors.  Kurt Bolin and the Stone Point team have a long track record with insurance and longevity-related assets, and I very much look forward to hearing his insights on the current state of the market.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. The $495 early bird registration fee includes cocktails and dinner immediately following the Conference.

THE 2020 FASANO
LONGEVITY CONFERENCE:

BEST VALUE EVER!

• Its Virtual: No cocktails or dinner this year; but we will make it feel real with live Q&A following every presentation

• All Substance: Our Agenda this year maintains Fasano’s preeminence in delivering fresh, relevant presentations affecting the longevity markets. Topics will include:
  • Epigenetics and Biomarkers: A New Age in Longevity Modeling
  • COVID-19: Financial, Mortality and Psychological Impact
  • Private Equity Perspective on Life Settlements
  • Outlook for Structured Settlements
  • 2020 Election Predictions

• Best Value: At $195, the 2020 Fasano Conference is a compelling value!

REGISTER NOW!

The quality of life expectancy estimates is one key consideration for an investor in life settlements. The predominant metric for assessing this quality is the so-called A-to-E ratio, which relies on a comparison of the actual to the predicted number of deaths. In this article, we explain key issues with this metric: In the short run, it is subject to estimation uncertainty for small and moderately sized portfolios; and, more critically, in the long run, it converges to 100% even if the underwriting is systematically biased. As an alternative, we propose and discuss a set of new metrics based on the difference in (temporary) life expectancies. We examine the underwriting quality of a leading U.S. life expectancy provider based on this new methodology.

To view the full article, click the button below.

Fasano Associates President, Mike Fasano, discusses the valuable new medical information that will be available from wearable devices, as well as possible underwriting applications for Big Data analyses.

If you are unable to view this link, please contact us at techsupport@fasanoassociates.com or 202-457-8188.

Fasano Associates, a premier life expectancy provider in the life settlement space, has developed a new proprietary mortality table and underwriting methodology for the Life Contingent – Structured Settlement business. View the video below; Fasano Associates President, Michael Fasano, demonstrates and explains the ground breaking underwriting enhancements that have improved life expectancy predictions in the growing structured settlement market.

If you are unable to view this link, please contact us at techsupport@fasanoassociates.com or 202-457-8188.

Drs. Daniel Bauer (Georgia State University) and Jochen Russ (Institute for Actuarial Studies) presented a new methodology for measuring Actual to Expected accuracy at the 9th Annual Fasano Life Settlement & Longevity Conference. The new methodology, Difference in Curtate Life Expectancy (DCLE), calculates the average difference between the actual and expected number of months lived, and is less biased than other methodologies. When applied to the entire Fasano life settlement database, Fasano’s average difference between actual and expected months of survival was less than one month.

Bauer and Russ then sorted Fasano’s DCLE by date of underwriting, as summarized in the following table:

Copies of Drs. Bauer and Russ’ slides are available at www.ifa-ulm.de/downloads/DCLE.pdf. Copies of the subsequent article they published on this methodology are available here.

Rajiv Rebello, a fellow of the Society of Actuaries, a member of the Academy and a Chartered Enterprise Risk Analyst, has written an article titled “Poor Underwriting Practices Spark Life Settlement Losses”. He is a principal of Colva Insurance Services in San Diego. His email address appears at the conclusion of the article. Mr. Rebello’s comment “Discounting historical results in favor of better expectations of future mortality offer life settlement investors a false sense of confidence in the accuracy of the underwriting”, captures the essence of today’s industry discussion. Click here to read entire article.

A Publication for Professional Traders and Institutional Investors.

LIFE MARKETS — Trading Mortality and Longevity Risk with Life Settlements and Linked Securities

Internationally acclaimed expert Vishaal Bhugan, Managing Partner of VB Bhuyan & Co., ‘and a team of coauthors, including Fasano Associates’ President, MICHAEL FASANO, and others from leading financial institutions, hedge funds, actuarial firms, law firms and universities provide a complete analysis of the life settlements market and show how to trade with confidence in the burgeoning market’. Comprehensive in scope ‘Life Markets’ covers a wealth of material touching on everything from the history of life settlements to making a transaction—pricing, service providers, and exchanges.

YOU SHOULD NOT MISS THIS ONE — order your copy directly from the publisher, John Wiley & Sons, Inc.

An Institutional Investors Guide to the Burgeoning Field of Reverse Mortgage Securitization.

REVERSE MORTGAGES and LINKED SECURITIES: The Complete Guide to Risk, Pricing, and Regulation by Vishaal B. Bhuyan is a collaborative effort of many of the leading minds in the Home Equity Conversion Mortgages (HECM) industry, including reverse mortgage lenders, institutional investors, underwriters, attorneys and regulators.

Michael Fasano was tapped to share his professional experience from life settlement underwriting and to explain how more sophisticated underwriting could be a boon to the reverse mortgage market.

The book discusses the securitization of reverse mortgages and other linked securities and includes coverage of pricing techniques and risk mitigation, and is one of the only guides to reverse mortgages and linked securities targeted towards institutional investors interested in securitized products.

A MUST READ BOOK —  order your copy directly from the publisher, John Wiley & Sons, Inc.

Developed to be used as a SCREENING TOOL for life settlement acquisitions and to assist individuals in financial planning applications. A “user friendly” tool that does not require the assistance of underwriters OR other professionals to complete. Not a replacement for the “real thing” BUT an inexpensive way to assess case value – easy to use while providing good risk discrimination. To try “ALEC”, click on the link in the left sidebar.

Fasano Associates is a diversified underwriting organization serving the life insurance, annuity/structured settlement, life settlement and related industries.  We have chosen to diversify within the underwriting domain, which has allowed us to leverage our analytic strengths. CLICK HERE to view the entire article.